Latest Articles
- Using C-reactive protein to assess cardiovascular disease risk
CRP is now a recognized cardiac test. But who should he tested?
Recombinant human PTH 1-34 (Forteo): An anabolic drug for osteoporosisWe have an important new drug for osteoporosis. Now who should get it? And who will pay for it?
- The promise of molecular biology: Efficacy, safety, wallet depletion
Molecular biology is entering its second wave, with effective but expensive treatments. Recombinant human parathyroid hormone (PTH) is a case in point.
- Amiodarone-induced thyrotoxicosis: Diagnostic and therapeutic strategies
It is difficult but important to distinguish the two types of amiodarone-induced thyrotoxicosis.
